Selective Laser Trabeculoplasty

Survey of Ophthalmology

Volumn 52, Issue 6, 2007, Pages 634-654

  Barkana, Yaniv ^a   Belkin, Michael ^b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

argon laser trabeculoplasty; glaucoma; intraocular pressure; pigmented cells; selective laser trabeculoplasty

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; CORTICOSTEROID; LATANOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE ACETATE;

ARGON LASER; BLEEDING; BLURRED VISION; CLINICAL STUDY; COMPARATIVE STUDY; ENERGY ABSORPTION; EXFOLIATION SYNDROME; EYE BURN; EYE DISCOMFORT; EYE DISEASE; EYE INFLAMMATION; EYE PAIN; GLAUCOMA; HUMAN; HYPHEMA; INTERMETHOD COMPARISON; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER TRABECULOPLASTY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THERAPY EFFECT; TRABECULAR MESHWORK; TRABECULOPLASTY; TREATMENT INDICATION; TREATMENT RESPONSE; YAG LASER;

GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LASER THERAPY; SURGICAL PROCEDURES, ELECTIVE; TRABECULECTOMY; TREATMENT OUTCOME;

EID: 36048967842     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2007.08.014     Document Type: Review

References (120)

1. Acott T.S., Samples J.R., Bradley J.M., et al. Trabecular repopulation by anterior trabecular meshwork cells after laser trabeculoplasty. Am J Ophthalmol 107 (1989) 1-6
2. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. Ophthalmol 134 (2002) 481-498
3. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
4. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol 132 (2001) 311-320
5. Albright C.D., Schuman S.G., and Netland P.A. Usage and cost of laser trabeculoplasty in the United States. Ophthalmic Surg Lasers 33 (2002) 334-336
6. Alexander R.A., Grierson I., and Church W.H. The effect of argon laser trabeculoplasty upon the normal human trabecular meshwork. Graefes Arch Clin Exp Ophthalmol 227 (1989) 72-77
7. Allf B.E., and Shields M.B. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine. Ophthalmic Surg 22 (1991) 539-542
8. Alvarado J.A., Alvarado R.G., Yeh R.F., et al. A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells. Br J Ophthalmol 89 (2005) 1500-1505
9. Anderson R.R., and Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220 (1983) 524-527
10. Ang A., Reddy M.A., Shepstone L., and Broadway D.C. Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. Br J Ophthalmol 88 (2004) 630-634
11. Asrani S., Zeimer R., Wilensky J., et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 9 (2000) 134-142
12. Barnes S.D., Campagna J.A., Dirks M.S., and Doe E.A. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%. Ophthalmology 106 (1999) 2033-2037
13. Bradley J.M., Anderssohn A.M., Colvis C.M., et al. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha. Invest Ophthalmol Vis Sci 2000 41 (2000) 422-430
14. Brinkmann R., Huttmann G., Rogener J., et al. Origin of retinal pigment epithelium cell damage by pulsed laser irradiance in the nanosecond to microsecond time regimen. Lasers Surg Med 27 (2000) 451-464
15. Broadway D.C., Grierson I., O'Brien C., and Hitchings R.A. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile. Arch Ophthalmol 112 (1994) 1437-1445
16. Broadway D.C., Grierson I., O'Brien C., and Hitchings R.A. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112 (1994) 1446-1454
17. Brubaker R.F., and Liesegang T.J. Effect of trabecular photocoagulation on the aqueous humor dynamics of the human eye. Am J Ophthalmol 96 (1983) 139-147
18. Busbee B.G., Recchia F.M., Kaiser R., et al. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes. Ophthalmology 111 (2004) 1495-1503
19. Bylsma S.S., Samples J.R., Acott T.S., and Van Buskirk E.M. Trabecular cell division after argon laser trabeculoplasty. Arch Ophthalmol 106 (1988) 544-547
20. Chen E., Golchin S., and Blomdahl S. A comparison between 90 degrees and 180 degrees selective laser trabeculoplasty. J Glaucoma 13 (2004) 62-65
21. Chen T.C., Ang R.T., Grosskreutz C.L., et al. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery. Ophthalmology 108 (2001) 1033-1038
22. Chiba T., Kashiwagi K., Ishijima K., et al. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn J Ophthalmol 48 (2004) 141-147
23. Chung P.Y., Schuman J.S., Netland P.A., et al. Five-year results of a randomized, prospective, clinical trial of diode vs argon laser trabeculoplasty for open-angle glaucoma. Am J Ophthalmol 126 (1998) 185-190
24. Cvenkel B. One-year follow-up of selective laser trabeculoplasty in open-angle glaucoma. Ophthalmologica 218 (2004) 20-25
25. Cvenkel B., Hvala A., Drnovsek-Olup B., and Gale N. Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplasty. Lasers Surg Med 33 (2003) 204-208
26. Damji K.F., Bovell A.M., Hodge W.G., et al. Selective laser trabeculoplasty vs. argon laser trabeculoplasty: results from a one-year randomised clinical trial. Br J Ophthalmol 90 (2006) 1490-1494
27. Damji K.F., Shah K.C., Rock W.J., et al. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol 83 (1999) 718-722
28. DeBry P.W., Perkins T.W., Heatley G., et al. Incidence of late-onset bleb-related complications following trabeculectomy with Mitomycin. Arch Ophthalmol 120 (2002) 297-300
29. Dueker D.K., Norberg M., Johnson D.H., et al. Stimulation of cell division by argon and Nd:YAG laser trabeculoplasty in cynomolgus monkeys. Invest Ophthalmol Vis Sci 31 (1990) 115-124
30. Ederer F., Gaasterland D.A., Dally L.G., et al. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 111 (2004) 651-664
31. Elsas T., Junk H., and Johnsen H. Diurnal intraocular pressure after successful primary laser trabeculoplasty. Am J Ophthalmol 112 (1991) 67-69
32. Englert J.A., Cox T.A., Allingham R.R., and Shields M.B. Argon vs diode laser trabeculoplasty. Am J Ophthalmol 12 (1997) 627-631
33. Feldman R.M., Katz L.J., Spaeth G.L., et al. Long-term efficacy of repeat argon laser trabeculoplasty. Ophthalmology 98 (1991) 1061-1065
34. Francis B.A., Ianchulev T., Schofield J.K., and Minckler D.S. Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma. Am J Ophthalmol 140 (2005) 524-525
35. Goldman A.I., Ham Jr. W.T., and Mueller A.H. Ocular damage thresholds and mechanisms for ultrashort pulses of both visible and infrared laser radiation in the rhesus monkey. Exp Eye Res 24 (1977) 45-56
36. Gracner T. Intraocular pressure response of capsular glaucoma and primary open-angle glaucoma to selective Nd:YAG laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol 12 (2002) 287-292
37. Gracner T. Intraocular pressure response to selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Ophthalmologica 215 (2001) 267-270
38. Grayson D.K., Camras C.B., Podos S.M., and Lustgarten J.S. Long-term reduction of intraocular pressure after repeat argon laser trabeculoplasty. Am J Ophthalmol 106 (1988) 312-321
39. Greenidge K.C., Spaeth G.L., and Fiol-Silva Z. Effect of argon laser trabeculoplasty on the glaucomatous diurnal curve. Ophthalmology 90 (1983) 800-804
40. Guzey M., Arslan O., Tamcelik N., and Satici A. Effects of frequency-doubled Nd:YAG laser trabeculoplasty on diurnal intraocular pressure variations in primary open-angle glaucoma. Ophthalmologica 213 (1999) 214-218
41. Guzey M., Vural H., Satici A., Karadede S., and Dogan Z. Increase of free oxygen radicals in aqueous humour induced by selective Nd:YAG laser trabeculoplasty in the rabbit. Eur J Ophthalmol 11 (2001) 47-52
42. Harasymowycz P.J., Papamatheakis D.G., Latina M., et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 139 (2005) 1110-1113
43. Heijl A., Leske M.C., Bengtsson B., et al. Early manifest glaucoma trial group, reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120 (2002) 1268-1279
44. Herbort C.P., Mermoud A., Schnyder C., and Pittet N. Anti-inflammatory effect of diclofenac drops after argon laser trabeculoplasty. Arch Ophthalmol 111 (1993) 481-483
45. Higginbotham E.J. Reaffirming the role of the laser in glaucoma management. Arch Ophthalmol 117 (1999) 1075-1076
46. Hodge W.G., Damji K.F., Rock W., et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol 89 (2005) 1157-1160
47. Jampel H.D., Musch D.C., Gillespie B.W., et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140 (2005) 16-22
48. Johnson P.B., Katz L.J., and Rhee D.J. Selective laser trabeculoplasty: predictive value of early intraocular pressure measurements for success at 3 months. Br J Ophthalmol 90 (2006) 741-743
49. Jampel H.D. Initial treatment for open-angle glaucoma- medical, laser, or surgical? Laser trabeculoplasty is the treatment of choice for chronic open-angle glaucoma. Arch Ophthalmol 116 (1998) 240-241
50. Juzych M.S., Chopra V., Banitt M.R., et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 111 (2004) 1853-1859
51. Kajiya S., Hayakawa K., and Sawaguchi S. Clinical results of selective laser trabeculoplasty. Jpn J Ophthalmol 44 (2000) 574-575
52. Kass M.A., Heuer D.K., Higginbotham E.J., et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120 (2002) 701-713
53. Kelly W.M., and Lin C.P. Microcavitation and cell injury in RPE cells following short-pulsed laser irradiation. Proc SPIE 2975 (1997) 174-179
54. Kim Y.J., and Moon C.S. One-year follow-up of laser trabeculoplasty using Q-switched frequency-doubled Nd:YAG laser of 523 nm wavelength. Ophthalmic Surg Lasers 31 (2000) 394-399
55. Kim Y.Y., Glover B.K., Shin D.H., et al. Effect of topical anti-inflammatory treatment on the long-term outcome of laser trabeculoplasty. Fluorometholone-Laser Trabeculoplasty Study Group. Am J Ophthalmol 126 (1998) 721-723
56. Koller T., Stürmer J., Remé C., and Gloor B. Membrane formation in the chamber angle after failure of argon laser trabeculoplasty: analysis of risk factors. Br J Ophthalmol 84 (2000) 48-53
57. Kramer T.R., and Noecker R.J. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology 108 (2001) 773-779
58. Krupin T., Kolker A.E., Kass M.A., and Becker B. Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmology 91 (1984) 361-365
59. Lai J.S., Chua J.K., Tham C.C., and Lam D.S. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol 32 (2004) 368-372
60. Lanzetta P., Menchini U., and Virgili G. Immediate intraocular pressure response to selective laser trabeculoplasty. Br J Ophthalmol 83 (1999) 29-32
61. Latina M.A., and Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 60 (1995) 359-371
62. Latina M.A., Sibayan S.A., Shin D.H., et al. Q-switched 532nm Nd-YAG laser trabeculoplasty (selective trabeculoplasty), a multicenter, pilot, clinical study. Ophthalmology 105 (1998) 2082-2090
63. Lee M.D., Fechtner F.R., Fiscella R.G., et al. Emerging perspectives on glaucoma: highlights of a roundtable discussion. Am J Ophthalmol 130 Suppl (2000) S1-S11
64. Lee R., and Hutnik C.M. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario health insurance plan. Can J Ophthalmol 41 (2006) 449-456
65. Lichter P.R., Musch D.C., Gillespie B.W., et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108 (2001) 1943-1953
66. Lin C.P., Kelly M.W., Sibayan S.A., et al. Selective cell killing by microparticle absorption of pulsed laser radiation. IEEE J Select Topics Quant Electron 5 (1999) 963-968
67. Lotti R., Traverso C.E., Murialdo U., et al. Argon laser trabeculoplasty: long-term results. Ophthalmic Surg 26 (1995) 127-129
68. Lustgarten J., Podos S.M., Ritch R., et al. Laser trabeculoplasty. A prospective study of treatment variables. Arch Ophthalmol 102 (1984) 517-519
69. Mainster M.A., Sliney D.H., Belcher III C.D., and Buzney S.M. Laser photodisruptors, damage mechanisms, instrument design and safety. Ophthalmology 90 (1983) 973-991
70. Marshall J. Thermal and mechanical mechanisms in laser damage to the retina. Invest Ophthalmol 9 (1970) 97-115
71. Martinez-de-la-Casa J.M., Garcia-Feijoo J., Castillo A., et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye 18 (2004) 498-502
72. Mchugh D., Marshall J., Ffytche T.J., et al. Ultrastructural changes of human trabecular meshwork after photocoagulation with a diode laser. Invest Ophthalmol Vis Sci 33 (1992) 2664-2671
73. McIlraith I., Strasfeld M., Colev G., and Hutnik C.M. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 15 (2006) 124-130
74. Melamed S., Ben Simon G.J., and Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 121 (2003) 957-960
75. Melamed S., Pei J., and Epstein D.L. Short-term effect of argon laser trabeculoplasty in monkeys. Arch Ophthalmol 103 (1985) 1546-1552
76. Mermoud A., Pittet N., and Herbort C.P. Inflammation patterns after laser trabeculoplasty measured with a laser flare meter. Arch Ophthalmol 110 (1992) 368-370
77. Nagar M., Ogunyomade A., O'brart D.P., et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 89 (2005) 1413-1417
78. Nelson W.L., Fraunfelder F.T., Sills J.M., et al. Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 102 (1986) 606-611
79. Noecker R.J., Herrygers L.A., and Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea 23 (2004) 490-496
80. Nordstrom B.L., Friedman D.S., Mozaffari E., et al. Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140 (2005) 598-606
81. Nouri-Mahdavi K., Hoffman D., Coleman A.L., et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 111 (2004) 1627-1635
82. Odberg T., and Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand 77 (1999) 176-181
83. Olthoff C.M., Schouten J.S., van de Borne B.W., and Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 112 (2005) 953-961
84. Osborne S.A., Montgomery D.M., Morris D., and McKay I.C. Alphagan allergy may increase the propensity for multiple eye-drop allergy. Eye 19 (2005) 129-137
85. Parshley D.E., Bradley J.M., Fisk A., et al. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells. Invest Ophthalmol Vis Sci 37 (1996) 795-804
86. Priebe L.A., Cain C.P., and Welch A.J. Temperature rise required for production of minimal lesions in the Macaca mulatta retina. Am J Ophthalmol 79 (1975) 405-413
87. Rasmussen C.A., and Kaufman P.L. Primate glaucoma models. J Glaucoma 14 (2005) 311-314
88. Reiss G.R., Wilensky J.T., and Higginbotham E.J. Laser trabeculoplasty. Surv Ophthalmol 35 (1991) 407-428
89. Richter C.U., Shingleton B.J., Bellows A.R., et al. Retreatment with argon laser trabeculoplasty. Ophthalmology 94 (1987) 1085-1089
90. Richter C.U., Shingleton B.J., Bellows A.R., et al. The development of encapsulated filtering blebs. Ophthalmology 95 (1988) 1163-1168
91. Robin A.L., and Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?. Ophthalmology 112 (2005) 863-868
92. Robin A.L., and Pollack I.P. Argon laser trabeculoplasty in secondary forms of open-angle glaucoma. Arch Ophthalmol 101 (1983) 382-384
93. Rodrigues M.M., Spaeth G.L., and Donohoo P. Electron microscopy of argon laser therapy in phakic open-angle glaucoma. Ophthalmology 89 (1982) 198-210
94. Roider J., Brinkmann R., Wirbelauer C., et al. Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol 117 (1999) 1028-1034
95. Roider J., El Hifnawi E.S., and Birngruber R. Bubble formation as primary interaction mechanism in retinal laser exposure with 200-ns laser pulses. Lasers Surg Med 22 (1998) 240-248
96. Roider J., Hillenkamp F., Flotte T., and Birngruber R. Microphotocoagulation: selective effects of repetitive short laser pulses. Proc Natl Acad Sci USA 90 (1993) 8643-8647
97. Roider J., Lindemann C., el-Hifnawi e.-S., et al. Therapeutic range of repetitive nanosecond laser exposures in selective RPE photocoagulation. Graefes Arch Clin Exp Ophthalmol 236 (1998) 213-219
98. Roider J., Michaud N.A., Flotte T.J., and Birngruber R. Response of the retinal pigment epithelium to selective photocoagulation. Arch Ophthalmol 110 (1992) 1786-1792
99. Rouhiainen H.J., Terasvirta M.E., and Tuovinen E.J. Peripheral anterior synechiae formation after trabeculoplasty. Arch Ophthalmol 106 (1988) 189-191
100. Ruderman J.M., Zweig K.O., Wilensky J.T., and Weinreb R.N. Effects of corticosteroid pretreatment on argon laser trabeculoplasty. Am J Ophthalmol 96 (1983) 84-89
101. Schwartz A.L., Van Veldhuisen P.C., Gaasterland D.E., et al. The Advanced Glaucoma Intervention Study (AGIS), 5. Encapsulated bleb after initial trabeculectomy. Am J Ophthalmol 127 (1999) 8-19
102. Shihadeh W.A., Ritch R., and Liebmann J.M. Hyphema occurring during selective laser trabeculoplasty. Ophthalm Surg Lasers Imaging 37 (2006) 432-433
103. Sherwood M.B., and Svedbergh B. Argon laser trabeculoplasty in exfoliation syndrome. Br J Ophthalmol 69 (1985) 886-890
104. Shingleton B.J., Richter C.U., Dharma S.K., et al. Long-term efficacy of argon laser trabeculoplasty, a 10-year follow-up study. Ophthalmology 100 (1993) 1324-1329
105. Song J., Lee P.P., Epstein D.L., et al. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma 14 (2005) 400-408
106. Spurny R.C., and Lederer Jr. C.M. Krypton laser trabeculoplasty, a clinical report. Arch Ophthalmol 102 (1984) 1626-1628
107. Stewart W.C., Konstas A.G., and Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther 20 (2004) 461-469
108. Tamada Y., Taniguchi T., Murase H., et al. Intraocular pressure-lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma. J Ocul Pharmacol Ther 17 (2001) 19-25
109. The Advanced Glaucoma Intervention Study (AGIS). 4. Comparison of treatment outcomes within race, seven-year results. Ophthalmology 105 (1998) 1146-1164
110. Glaucoma Laser Trial Research Group. The glaucoma laser trial, I. Acute effects of argon laser trabeculoplasty on intraocular pressure. Arch Ophthalmol 107 (1989) 1135-1142
111. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study, seven-year results. Am J Ophthalmol 120 (1995) 718-731
112. The Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT), 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology 97 (1990) 1403-1413
113. Threlkeld A.B., Hertzmark E., Sturm R.T., et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma 5 (1996) 311-316
114. Traverso C.E., Greenidge K.C., and Spaeth G.L. Formation of peripheral anterior synechiae following argon laser trabeculoplasty, a prospective study to determine relationship to position of laser burns. Arch Ophthalmol 102 (1984) 861-863
115. van der Zypen E., and Fankhauser F. Ultrastructural changes of the trabecular meshwork of the monkey (Macaca speciosa) following irradiation with argon laser light. Graefes Arch Clin Exp Ophthalmol 221 (1984) 249-261
116. Weinreb R.N., Ruderman J., Juster R., and Zweig K. Immediate intraocular pressure response to argon laser trabeculoplasty. Am J Ophthalmol 95 (1983) 279-286
117. Werner M., Smith M.F., and Doyle J.W. Selective laser trabeculoplasty in phakic and pseudophakic eyes. Ophthalmic Surg Lasers Imaging 38 (2007) 182-188
118. Wimmer I., Welge-Luessen U., Picht G., and Grehn F. Influence of argon laser trabeculoplasty on transforming growth factor-beta 2 concentration and bleb scarring following trabeculectomy. Graefes Arch Clin Exp Ophthalmol 241 (2003) 631-636
119. Wise J.B., and Witter S.L. Argon laser therapy for open-angle glaucoma, a pilot study. Arch Ophthalmol 97 (1979) 319-322
120. Yablonski M.E., Cook D.J., and Gray J. A fluorophotometric study of the effect of argon laser trabeculoplasty on aqueous humor dynamics. Am J Ophthalmol 99 (1985) 579-582